Cidara Therapeutics (NASDAQ:CDTX) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $35.00 price objective on the biotechnology company’s stock. Several other equities analysts have also commented on CDTX. WBB Securities upped their price target on Cidara […]
Needham & Company LLC reiterated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $35.00 price objective on the biotechnology company’s stock. Several other equities analysts have also commented on CDTX. WBB Securities upped their price target on Cidara […]
